4D Molecular Therapeutics Stock Performance
as on September 22, 2026 at 6:59 am IST
Day's Low
Day's High
$14.68$15.61
3.67%
Downside
2.43%
Upside
52 Week's Low
52 Week's High
$6.47$16.9357.57%
Downside
11.09%
Upside
4D Molecular Therapeutics share price movements today
- Previous Close
- $15.22
- Open
- $15.37
- Volume
- 605.7K
- Market Cap
- $840.8M
- Day's Low - High
- $14.68 - $15.61
- 52 Week Low - High
- $6.47 - $16.93
4D Molecular Therapeutics Historical Returns
- 1 Month Return
- -3.85 %
- 3 Month Return
- + 57.56 %
- 1 Year Return
- + 130.61 %
- 3 Year Return
- + 5.33 %
- 5 Year Return
- -56.53 %
4D Molecular Therapeutics Stock Fundamentals & Key Indicators
Check 4D Molecular Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$840.8M
EPS (TTM)
-2.72
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-5.4
Industry PE ratio
-6.94
PEG Ratio
-0.36787948426287514
EBITDA
-184.9M
Revenue (TTM)
92.0M
Profit Margin
42.00%
Return On Equity TTM
-41.33%
4D Molecular Therapeutics Stock Valuation
Track how 4D Molecular Therapeutics P/E has moved over time to understand its valuation trends.
4D Molecular Therapeutics in the last 5 years
Lowest (-8.53x)
December 31, 2021
Industry (-6.94x)
December 31, 2025
Today (-3.10x)
December 31, 2025
Highest (-1.87x)
December 31, 2024
Today’s Price to Earnings Ratio: -3.10x
4D Molecular Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of 4D Molecular Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $840.8M | -56.53% | -5.4 | 42.00% | 0.00% | |
| Neutral | $61.5B | -64.51% | -19.3 | -12.57% | 0.00% | |
| StrongBuy | $130.1B | 174.21% | 29.81 | 86.04% | 0.00% | |
| Buy | $80.8B | 21.32% | 18.48 | 84.86% | 0.47% |
Stock Returns calculator for 4D Molecular Therapeutics Stock including INR - Dollar returns
The 4D Molecular Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
4D Molecular Therapeutics investment value today
Current value as on today
₹2,50,527
Returns
₹1,50,527
(+150.53%)
Returns from 4D Molecular Therapeutics Stock
₹1,30,909 (+130.91%)
Dollar Impact
₹19,617 (+19.62%)
Analyst Recommendation on 4D Molecular Therapeutics Stock
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.88888888888889% of analysts recommend a 'BUY' rating for 4D Molecular Therapeutics. Average target price of $27.82
4D Molecular Therapeutics Share Price Target
Get share price movements and forecasts by analysts on 4D Molecular Therapeutics.
What analysts predicted
45.22%UPSIDE
Target Price
$27.82
Current Price
$15.24
Analyzed by
9 Analysts
Target
$27.82
4D Molecular Therapeutics target price $27.82, a slight upside of 45.22% compared to current price of $15.24. According to 9 analysts rating.
Indian Investors' Interest in 4D Molecular Therapeutics Stock
Search interest for 4D Molecular Therapeutics Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
4D Molecular Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
4D Molecular Therapeutics Annual Profit & Loss
All numbers in Millions USD
4D Molecular Therapeutics Quarterly Cash Flow
All numbers in Millions USD
4D Molecular Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on 4D Molecular Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 3.04M → 3.78M (in $), with an average increase of 19.4% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, FDMT stock has moved up by 10.6%
NO EFFECTAgainst Peers
In the last 3 years, Moderna, Inc. Common Stock has given 53.7% return, outperforming this stock by 48.4%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 379.7%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, 19.39M → -72.93M (in $), with an average decrease of 230.3% per quarter
About 4D Molecular Therapeutics
| Organisation | 4D Molecular Therapeutics |
| Headquarters | 5858 Horton Street, EmeryVille, CA, 94608, US |
| Industry | Biotechnology |
| CEO | David H. Kirn |
| E-voting on shares | Click here to vote |
Key Management of 4D Molecular Therapeutics
Name | Title |
|---|---|
Dr. Fariborz Kamal Ph.D. | Chief Technical Advisor |
Julian Pei | Head of Investor Relations & Corporate Finance |
Dr. Katy Barglow Ph.D. | Chief Technical Officer |
Dr. Noriyuki Kasahara M.D., Ph.D. | Chief Scientific Advisor |
Dr. Scott P. Bizily J.D., Ph.D. | Chief Legal Officer & Corporate Secretary |
Dr. An Song Ph.D. | Chief Translational Medicine Advisor |
Dr. John F. Milligan Ph.D. | Executive Chairman |
Dr. David H. Kirn M.D. | Co-Founder, President, CEO & Director |
Mr. Kristian Humer M.B.A. | CFO and Principal Financial & Accounting Officer |
Ms. Theresa Janke | Co-Founder & Chief of Staff |
FAQs
What is 4D Molecular Therapeutics share price today?
4D Molecular Therapeutics share price today is $15.24 as on at the close of the market. 4D Molecular Therapeutics share today touched a day high of $15.61 and a low of $14.68.
What is the 52 week high and 52 week low for 4D Molecular Therapeutics share?
4D Molecular Therapeutics share touched a 52 week high of $16.93 on and a 52 week low of $6.47 on . 4D Molecular Therapeutics stock price today i.e. is closed at $15.24,which is 9.98% down from its 52 week high and 135.67% up from its 52 week low.
What is 4D Molecular Therapeutics's market capitalisation today?
4D Molecular Therapeutics market capitalisation is $0.00T as on .
How to invest in 4D Molecular Therapeutics Stock (FDMT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for 4D Molecular Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in 4D Molecular Therapeutics Shares that will get you 0.0984 shares as per 4D Molecular Therapeutics share price of $15.24 per share as on September 22, 2026 at 1:29 am IST.
What is the minimum amount required to buy 4D Molecular Therapeutics Stock (FDMT) from India?
Indian investors can start investing in 4D Molecular Therapeutics (FDMT) shares with as little as ₹95.805 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.05 in 4D Molecular Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on 4D Molecular Therapeutics share’s latest price of $15.24 as on September 22, 2026 at 1:29 am IST, you will get 0.6562 shares of 4D Molecular Therapeutics. Learn more about
fractional shares .
What are the returns that 4D Molecular Therapeutics has given to Indian investors in the last 5 years?
4D Molecular Therapeutics stock has given -56.53% share price returns and 30.09% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?